Results 231 to 240 of about 4,079,288 (357)

Global analysis of excitotoxicity-induced alterations in RNA structure and RNA-protein binding in neurons. [PDF]

iScience
Alvarez-Periel E, Kramer MC, Akay-Espinoza C, Jackson DP, Tasca JA, Garcia BA, Gregory BD, Jordan-Sciutto KL.   +7 more
europepmc   +1 more source

Determination of Protein in Dairy Products by Dye-Binding

, 1966
U. S. Ashworth
openalex   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

The role of LRRC15-SCG5 in ECM protein binding as a prognostic signature for urothelial carcinoma. [PDF]

Am J Cancer Res
Dong SW, Chen CH, Tzou KY, Hu SW, Wu CC, Li CH.   +5 more
europepmc   +1 more source

INHERITANCE OF A HEME-BINDING PROTEIN IN RABBITS

, 1966
A.A. GRUNDER
openalex   +2 more sources

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

RMDNet: RNA-aware dung beetle optimization-based multi-branch integration network for RNA-protein binding sites prediction. [PDF]

BMC Bioinformatics
Zhang J, Peng Y, Cui F, Zhang Z, Yan S, Zhang Q.   +5 more
europepmc   +1 more source

Hypomethylating agents increase L1 retroelement expression without inducing novel insertions in myeloid malignancies

Molecular Oncology, EarlyView.
We investigated whether hypomethylating agents (HMAs) used in myeloid malignancies induce somatic retrotransposition. Our findings indicate that HMA treatment increases L1‐encoded protein expression but does not lead to detectable de novo retrotransposition events in either patient samples or cell lines.
Šárka Pavlová, Hana Svozilová, Marcela Krzyžánková, Radim Sonnek, Anastasiya Volakhava, Anastasia Smirnova, Tatiana Grigoreva, Zuzana Jašková, Hana Synáčková, Dennis Wahl, Michaela Bilčíková, Libor Červinek, Šárka Pospíšilová, Ilgar Mamedov, Karla Plevová   +14 more
wiley   +1 more source

Insights into interspecies protein binding variability using clindamycin as an example. [PDF]

J Antimicrob Chemother
Ahmed H, Böhmdorfer M, Jäger W, Zeitlinger M.   +3 more
europepmc   +1 more source

Protein binding to DNA [PDF]

Nature, 1987
openaire   +3 more sources